The genus Acinetobacter is a heterogeneous group of organisms that comprises 17 named species and 15 species that have no valid names as of yet. Acinetobacter baumannii and the closely related ...

The Swiss drugmaker says the safety and efficacy of zosurabalpin will be investigated in a study involving 400 patients with ...

An experimental antibiotic, zosurabalpin, to fight a deadly superbug has entered the final human trials. Currently, no new ...

New ‘superbug’ antibiotic to treat sepsis and pneumonia enters last phase of testing - It is hoped that the drug zosurabalpin ...

Australia’s second-largest private hospital operator, Healthscope, is in receivership with ten non-binding offers for ...

Swiss drugmaker Roche said on Monday it would advance testing of an antibiotic against a common drug-resistant bacteria that ...

Hundreds of patients will be recruited for a major trial of what could be the first new antibiotic of its kind for 50 years.

Acinetobacter baumannii are bacteria that cause infections in the blood, lungs, kidneys, brain, and other organs. These bacteria are nonmotile (don't move on their own), strictly aerobic (need ...

The bacterium Acinetobacter baumannii is particularly feared, and there is great pressure to devise novel therapeutic approaches to combat it. Bioinformaticians have now detected an unexpectedly ...

Roche is moving its novel antibiotic zosurabalpin into phase 3 testing for carbapenem-resistant Acinetobacter baumannii (CRAB), a 'superbug' that is considered an 'urgent threat' by the CDC, in what ...

The bacteria, Acinetobacter baumannii, can cause serious infections in the lungs, urinary tract and blood, according to the US Centers for Disease Control and Prevention. It’s resistant to a ...